We found that patients with polymorphisms affecting the signaling of TLR4 and the high affinity ATP receptor, P2X7, were associated with a faster time to progression, thereby suggesting that anticancer immune responses driven through ICD are relevant in humans (80–82) (Figure 1). Here, P2RX7 is linked to impulse control disorder.